In conclusion, based on dynamic 18F-FET PET acquisition, we developed a full automatic clustering approach of TAC which appears to be a valuable noninvasive diagnostic (for IDH1 mutant status) and prognostic marker in patients with gliomas. This evidence concerns the gene IDH1 and central nervous system cancer.